In 2013, Stanya et al. demonstrated that IL-13 deficiency in mice leads to increased weight gain, hyperglycemia, and hepatic insulin resistance, which indicates that IL-13 might inhibit atherogenesis13. Here, IL13 is linked to Hyperglycemia.